Etanercept (Enbrel®) in Psoriasis - Pediatrics

• Status: Completed
• Trial end date: 2007-06-01
• Target enrollment: 0
• Participant gender: All

Summary

This study will evaluate the safety and efficacy of etanercept (Enbrel®) in children with Psoriasis.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Amgen
• Treatments: Etanercept

Criteria

• Patients with plaque psoriasis

• Patient may not receive certain psoriasis medications during the study